Vitrafy Life Sciences Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
19
- Stock Symbol
-
VFY
- Share Price
-
$1.60
- (As of Thursday Closing)
Vitrafy Life Sciences General Information
Description
Vitrafy Life Sciences Ltd is the research, development and commercialisation of its integrated cryopreservation solution. This includes cryopreservation medical devices (freezer, thawer and packaging solutions), Life Chain integrated software system, and services for application areas in human health and animal reproduction. The group has one operating segment. The company's solutions are LifeChain TM, and Guardion TM. LifeChain TM is the nexus of modern cryopreservation, an intelligent platform unifying data-driven optimization, world-wide logistics, and proprietary algorithms to create bespoke freeze curves. Guardion TM rapidly freezes T-cells in under four minutes while maintaining post-thaw quality rivaling fresh controls.
Contact Information
Website
www.vitrafy.comCorporate Office
- 80 Technology Drive
- Irvine, CA 92618
- United States
Corporate Office
- 80 Technology Drive
- Irvine, CA 92618
- United States
Vitrafy Life Sciences Timeline
Vitrafy Life Sciences Stock Performance
As of 19-Nov-2026, Vitrafy Life Sciences’s stock price is $1.60. Its current market cap is $122M with 76.2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.60 | $1.65 | $0.85 - $3.30 | $122M | 76.2M | 69.6K |
Vitrafy Life Sciences Financials Summary
As of 30-Sep-2026, Vitrafy Life Sciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 184,561 | 140,713 | 40,340 | |
| Revenue | 114 | 42 | 24 | |
| EBITDA | (11,396) | (17,416) | 5 | |
| Net Income | (10,955) | (21,164) | (6,832) | |
| Total Assets | 29,738 | 20,800 | 27,626 | |
| Total Debt | 208 | 256 | 317 |
Vitrafy Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vitrafy Life Sciences Patents
Vitrafy Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023902850-A0 | Method and system for controlling the processing of biological materials | Inactive | 05-Sep-2023 | ||
| AU-2024219387-A1 | Method and system for controlling the processing of biological materials | Pending | 05-Sep-2023 | ||
| EP-4774731-A1 | Method and system for controlling the processing of biological materials | Pending | 05-Sep-2023 | ||
| JP-2026533148-A | Method and system for controlling the processing of biological materials | Pending | 05-Sep-2023 | ||
| WO-2025050165-A1 | Method and system for controlling the processing of biological materials | Inactive | 05-Sep-2023 | G16B40/20 |
Vitrafy Life Sciences Signals
Vitrafy Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Vitrafy Life Sciences FAQs
-
When was Vitrafy Life Sciences founded?
Vitrafy Life Sciences was founded in 2017.
-
Where is Vitrafy Life Sciences headquartered?
Vitrafy Life Sciences is headquartered in Irvine, CA.
-
What is the size of Vitrafy Life Sciences?
Vitrafy Life Sciences has 19 total employees.
-
What industry is Vitrafy Life Sciences in?
Vitrafy Life Sciences’s primary industry is Other Devices and Supplies.
-
Is Vitrafy Life Sciences a private or public company?
Vitrafy Life Sciences is a Public company.
-
What is Vitrafy Life Sciences’s stock symbol?
The ticker symbol for Vitrafy Life Sciences is VFY.
-
What is the current stock price of Vitrafy Life Sciences?
As of 19-Nov-2026 the stock price of Vitrafy Life Sciences is $1.60.
-
What is the current market cap of Vitrafy Life Sciences?
The current market capitalization of Vitrafy Life Sciences is $122M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process